NCT01868438View on ClinicalTrials.gov

Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions
Malaria
Interventions
DRUG

Pyronaridine-artesunate granules

DRUG

Pyronaridine-artesunate tablets

Trial Locations (1)

Unknown

Dept. of Clinical Pharmacology and Therapeutics, Asan Medical Center, Univ. of Ulsan, Seoul

All Listed Sponsors
collaborator

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

lead

Medicines for Malaria Venture

OTHER

NCT01868438 - Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers | Biotech Hunter | Biotech Hunter